These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37500158)

  • 1. Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment.
    Nakane H; Sudo T; Kawahara A; Yomoda T; Shigaki T; Fujiyoshi K; Ohchi T; Koushi K; Yoshida T; Ogata T; Fujita F; Akagi Y
    Anticancer Res; 2023 Aug; 43(8):3793-3798. PubMed ID: 37500158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune-Related Factors as Prognostic Markers for Resectable Colorectal Cancer].
    Tomochika S; Kuwahara T; Suzuki N; Hazama S; Nagano H
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):325-330. PubMed ID: 33790150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
    Kim Y; Bae JM; Li G; Cho NY; Kang GH
    PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer.
    Alkatout I; Hübner F; Wenners A; Hedderich J; Wiedermann M; Sánchez C; Röcken C; Mathiak M; Maass N; Klapper W
    Exp Mol Pathol; 2017 Apr; 102(2):268-275. PubMed ID: 28232080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.
    Alwers E; Kather JN; Kloor M; Brobeil A; Tagscherer KE; Roth W; Echle A; Amitay EL; Chang-Claude J; Brenner H; Hoffmeister M
    J Pathol Clin Res; 2023 Mar; 9(2):129-136. PubMed ID: 36424650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
    Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
    Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of immunoscore related markers in bladder cancer.
    Ariafar A; Sanati A; Ahmadvand S; Shekarkhar G; Safaei A; Shayan Z; Faghih Z
    BMC Urol; 2022 Aug; 22(1):133. PubMed ID: 36038861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells.
    Song M; Nishihara R; Cao Y; Chun E; Qian ZR; Mima K; Inamura K; Masugi Y; Nowak JA; Nosho K; Wu K; Wang M; Giovannucci E; Garrett WS; Fuchs CS; Ogino S; Chan AT
    JAMA Oncol; 2016 Sep; 2(9):1197-206. PubMed ID: 27148825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density.
    Schnellhardt S; Hirneth J; Büttner-Herold M; Daniel C; Haderlein M; Hartmann A; Fietkau R; Distel L
    Front Immunol; 2022; 13():781222. PubMed ID: 35140715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8-positive T Cell Infiltration With Human Leukocyte Antigen Class 1 Expression Predicts Patients With Stage IV Colorectal Cancer Survival.
    Satoyoshi T; Hirohashi Y; Okuya K; Miyo M; Akizuki E; Ishii M; Miura R; Kubo T; Murata K; Kanaseki T; Tsukahara T; Takemasa I; Torigoe T
    Anticancer Res; 2024 Apr; 44(4):1603-1610. PubMed ID: 38537969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.
    Zeng L; Li SH; Xu SY; Chen K; Qin LJ; Liu XY; Wang F; Fu S; Deng L; Wang FH; Miao L; Li L; Liu N; Wang R; Wang HY
    Front Immunol; 2022; 13():878457. PubMed ID: 35619699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
    Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
    Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.
    Kasurinen J; Hagström J; Kaprio T; Beilmann-Lehtonen I; Haglund C; Böckelman C
    Tumour Biol; 2022; 44(1):37-52. PubMed ID: 35404299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.